Acrylamide fragment inhibitors that induce unprecedented conformational distortions in enterovirus 71 3C and SARS-CoV-2 main protease
文献类型:期刊论文
作者 | Qin B., Craven G.B., Hou P., Chesti J., Lu X., Child E.S., Morgan R.M.L., Niu W., Zhao L., Armstrong A., Mann D.J., Cui S. |
刊名 | Acta Pharmaceutica Sinica B
![]() |
出版日期 | 2022 |
卷号 | 12期号:10页码:3924-3933 |
ISSN号 | 2211-3835 |
DOI | 10.1016/j.apsb.2022.06.002 |
文献子类 | Article |
电子版国际标准刊号 | 2211-3843 |
语种 | 英语 |
源URL | [http://ir.ihep.ac.cn/handle/311005/299107] ![]() |
专题 | 高能物理研究所_多学科研究中心 |
作者单位 | 中国科学院高能物理研究所 |
推荐引用方式 GB/T 7714 | Qin B., Craven G.B., Hou P., Chesti J., Lu X., Child E.S., Morgan R.M.L., Niu W., Zhao L., Armstrong A., Mann D.J., Cui S.. Acrylamide fragment inhibitors that induce unprecedented conformational distortions in enterovirus 71 3C and SARS-CoV-2 main protease[J]. Acta Pharmaceutica Sinica B,2022,12(10):3924-3933. |
APA | Qin B., Craven G.B., Hou P., Chesti J., Lu X., Child E.S., Morgan R.M.L., Niu W., Zhao L., Armstrong A., Mann D.J., Cui S..(2022).Acrylamide fragment inhibitors that induce unprecedented conformational distortions in enterovirus 71 3C and SARS-CoV-2 main protease.Acta Pharmaceutica Sinica B,12(10),3924-3933. |
MLA | Qin B., Craven G.B., Hou P., Chesti J., Lu X., Child E.S., Morgan R.M.L., Niu W., Zhao L., Armstrong A., Mann D.J., Cui S.."Acrylamide fragment inhibitors that induce unprecedented conformational distortions in enterovirus 71 3C and SARS-CoV-2 main protease".Acta Pharmaceutica Sinica B 12.10(2022):3924-3933. |
入库方式: OAI收割
来源:高能物理研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。